SecProbe.io

CORRESP
1
filename1.htm

Basel
Medical Group Ltd

6
Napier Road,

Unit
#02-10/11 Gleneagles Medical Centre

Singapore
258499

Date:
November 14, 2024

Via
EDGAR

Division
of Corporation Finance

Office
of Energy & Transportation

U.S.
Securities and Exchange Commission

Washington,
D.C. 20549

    Attn.:
    Nudrat
                                            Salik

    Michael
    Fay

    Robert
    Augustin

    Jane
    Park

    Re:
    Basel
    Medical Group Ltd

    Registration
                                            Statement on Form F-1

    Filed
    November 4, 2024

    CIK
    No. 0002004489

    File
    No. 333-282096

Ladies
and Gentlemen:

Basel
Medical Group Ltd (the “Company”) is publicly filing its second amendment to the registration statement on Form F-1
(the “Registration Statement”) with the U.S. Securities and Exchanges Commission to include a resale prospectus section.

Kindly
address any comments or questions that you have concerning the Registration Statement to our attorneys Benjamin Tan Esq. and Martryn
Mak Esq. of Sichenzia Ross Ference Carmel LLP at (646) 810-0609 or btan@srfc.law and (646) 963-6393 or mmak@srfc.law.

Thank
you for your time and attention.

    Very
                                            truly yours,

    For
    and on behalf of

    Basel
    Medical Group Ltd

    /s/
    Raymond Wai Man Cheung

    Name:
    Raymond
    Wai Man Cheung

    Position:
    Chief
    Executive Officer